Movers & Shakers

Premium

ThermoGenesis has named Robin Stracey to its board of directors, replacing Mahendra Rao who has resigned in order to take a position at the National Institutes of Health.

Stracey is the president and CEO of Cantimer. Previously he was CEO of Applied Imaging, a medical devices company that is now a part of Danaher. He was also vice president and general manager of chromatography and mass spectrometry at Thermo Fisher Scientific.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.